NY State Senate Bill 2017-S1893

Archive: Last Bill Status - In Senate Committee Insurance Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2018	referred to insurance
Jan 11, 2017	referred to insurance

2017-S1893 (ACTIVE) - Details

See Assembly Version of this Bill:: A5273
Current Committee:: Senate Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in Other Legislative Sessions:: 2009-2010: A4131
2011-2012: S7180, A4724
2013-2014: S670, A6130
2015-2016: S695, A4477
2019-2020: A4899
2021-2022: A5032
2023-2024: A4494

2017-S1893 (ACTIVE) - Summary

Provides that every insurance policy which provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines "single source drug".

2017-S1893 (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S1893

 TITLE OF BILL :  An act to amend the insurance law, in relation to
coverage for single source drugs

 PURPOSE OR GENERAL IDEA OF THE BILL :

The purpose of this legislation is to require continued coverage of a
prescription drug if a patient was on such drug prior to a policy
change.

 SUMMARY OF PROVISIONS :

Section 1 of the bill amends the adds a new paragraph 33 to
subsection(i) of § 3216 of the insurance law to require continued
coverage of a prescription drug if such drug was previously covered
under an individual's insurance plan and no generic equivalent is
available.

Section 2 of the bill adds a new paragraph 21 to subsection (k) of §
3221 of the insurance law requiring each group policy to continue
coverage of a prescription drug during a grievance or an appeal when a
policy removes a prescription from the formulary while patient was
taking such drug as part of a prescribed therapy.

Section 3 of the bill adds a new subsection (qq) to § 4303 of the

insurance law requiring contracts issued by a health service
corporation or a medical expense indemnity corporation to continue
coverage of a prescription drug during a grievance or an appeal when a
policy removes a prescription from the formulary while the patient was
taking such drug as part of a prescribed therapy.

Section 4 sets forth an effective date of the first day of the
calendar month next succeeding the sixtieth day after it shall have
become a law but shall apply only to policies and contracts issued,
renewed or amended on or after the effective date of this act.

 JUSTIFICATION :

This legislation was modeled after a 1998 law in California. This bill
would require an insurance plan to continue their coverage of
prescription medication for patients currently taking the medication
when no generic equivalent is available.

When a patient is on a prescribed therapy it is very important for the
patient to maintain that therapy to the end. When a drug is dropped
from a plan, the consequences can be dire and/or costly for the
patients that are in various stages of therapy with that drug. If the
patient were to maintain the prescribed therapy, the out of pocket
cost to the patient could be so exorbitant that the patient would
eventually stop taking the prescription prior to the completion of the
therapy.

In another circumstance, the patient may be forced to change to a
similar brand name drug - that is covered under the plan- in the midst
of the prescribed therapy. That new drug may not be as suitable or may
cause adverse reactions. The new drug may not react well with other
medication that the patient is taking. Also, the new drug may not
achieve the desired effect that the other drug accomplished.

The physician should have the final say in which prescription a
patient takes. Although one drug may seem to have the same effect as
another, it may not be as compatible with other medications a patient
is taking or, one drug may be more effective under certain conditions.
In any event, health care cannot be directed by the bottom dollar in

every instance. When a patient's well-being is affected, policy must
be changed for the betterment of the patient.

 LEGISLATIVE HISTORY :

2015-16, S.695-A
2013-14, S.670/A.6130 (Ramos)
2011-12, S.7180/A.3718 (Rivera) (Enacting Clause Stricken)
2009-10, 5.5510 (Klein)/A.4191 (Rivera)
2007-08, A.6739 (Rivera)
2005-06, S.4084 (Alesi)/A.3035 (Rivera)
2003-04, S.4904-A (Alesi)/A.6012-A (Rivera)
2001-02, S.6588-8 (Alesi)/A.1912-C (Rivera)
1999-00, A.9448 (Colman)

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
This act shall take effect on the first day of the calendar month next
succeeding the sixtieth day after it shall have become a law but shall
apply only to policies and contracts issued, renewed or amended on or
after the effective date of this act.

2017-S1893 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1893
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                             January 11, 2017
                                ___________
 
 Introduced  by  Sen.  AVELLA -- read twice and ordered printed, and when
   printed to be committed to the Committee on Insurance
 
 AN ACT to amend the insurance law, in relation to  coverage  for  single
   source drugs
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
 amended by adding a new paragraph 34 to read as follows:
   (34) EVERY INDIVIDUAL OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIV-
 ERY  IN THIS STATE PROVIDING COVERAGE FOR PRESCRIPTION DRUGS THROUGH THE
 USE OF A DRUG FORMULARY SHALL INCLUDE A PROVISION WHICH, IN THE EVENT OF
 A CHANGE TO SUCH FORMULARY, ALLOWS A COVERED  PERSON  WHO  IS  TAKING  A
 SINGLE  SOURCE DRUG COVERED UNDER SUCH POLICY THAT IS NO LONGER INCLUDED
 IN OR PREFERRED UNDER SUCH FORMULARY AND HAS FILED  A  GRIEVANCE  OR  AN
 APPEAL  OF  THE DENIAL OF ACCESS TO THE DRUG WITH THE INSURER OR A STATE
 OR FEDERAL AGENCY OR DESIGNEE OF  SUCH  AGENCY,  TO  CONTINUE  RECEIVING
 COVERAGE  FOR  SUCH  DRUG  UNDER  THE SAME TERMS AND CONDITIONS AS WOULD
 APPLY UNDER THE POLICY WERE SUCH DRUG STILL  INCLUDED  IN  OR  PREFERRED
 UNDER THE FORMULARY, UNTIL A FINAL DECISION IS RENDERED ON THE APPEAL OR
 GRIEVANCE. FOR THE PURPOSE OF THIS PARAGRAPH, "SINGLE SOURCE DRUG" MEANS
 A BRANDNAME DRUG FOR WHICH THERE IS NO GENERIC EQUIVALENT.
   § 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 22 to read as follows:
   (22) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN
 THIS  STATE PROVIDING COVERAGE FOR PRESCRIPTION DRUGS THROUGH THE USE OF
 A DRUG FORMULARY SHALL INCLUDE A PROVISION WHICH,  IN  THE  EVENT  OF  A
 CHANGE TO SUCH FORMULARY, ALLOWS A COVERED PERSON WHO IS TAKING A SINGLE
 SOURCE  DRUG  COVERED UNDER SUCH POLICY THAT IS NO LONGER INCLUDED IN OR
 PREFERRED UNDER SUCH FORMULARY AND HAS FILED A GRIEVANCE OR AN APPEAL OF
 THE DENIAL OF ACCESS TO THE DRUG WITH THE INSURER OR A STATE OR  FEDERAL
 AGENCY  OR  DESIGNEE  OF SUCH AGENCY, TO CONTINUE RECEIVING COVERAGE FOR
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

                                                            LBD00584-01-7

 S. 1893                             2
 
 SUCH DRUG UNDER THE SAME TERMS AND CONDITIONS AS WOULD APPLY  UNDER  THE
 POLICY  WERE  SUCH  DRUG STILL INCLUDED IN OR PREFERRED UNDER THE FORMU-
 LARY, UNTIL A FINAL DECISION IS RENDERED ON THE APPEAL OR GRIEVANCE. FOR
 THE  PURPOSE  OF  THIS PARAGRAPH, "SINGLE SOURCE DRUG" MEANS A BRANDNAME
 DRUG FOR WHICH THERE IS NO GENERIC EQUIVALENT.
   § 3. Section 4303 of the insurance law is  amended  by  adding  a  new
 subsection (oo) to read as follows:
   (OO)  EVERY  CONTRACT  DELIVERED  OR ISSUED FOR DELIVERY IN THIS STATE
 PROVIDING COVERAGE FOR PRESCRIPTION DRUGS THROUGH  THE  USE  OF  A  DRUG
 FORMULARY  SHALL  INCLUDE A PROVISION WHICH, IN THE EVENT OF A CHANGE TO
 SUCH FORMULARY, ALLOWS A COVERED PERSON WHO IS TAKING  A  SINGLE  SOURCE
 DRUG  COVERED  UNDER  SUCH  CONTRACT  THAT  IS  NO LONGER INCLUDED IN OR
 PREFERRED UNDER SUCH FORMULARY AND HAS FILED A GRIEVANCE OR AN APPEAL OF
 THE DENIAL OF ACCESS TO THE DRUG WITH THE INSURER CORPORATION OR  ORGAN-
 IZATION  CERTIFIED  PURSUANT  TO ARTICLE FORTY-FOUR OF THE PUBLIC HEALTH
 LAW OR A STATE OR FEDERAL AGENCY OR DESIGNEE OF SUCH AGENCY, TO CONTINUE
 RECEIVING COVERAGE FOR SUCH DRUG UNDER THE SAME TERMS AND CONDITIONS  AS
 WOULD  APPLY  UNDER  THE  CONTRACT  WERE  SUCH DRUG STILL INCLUDED IN OR
 PREFERRED UNDER THE FORMULARY, UNTIL A FINAL DECISION IS RENDERED ON THE
 APPEAL OR GRIEVANCE. FOR THE PURPOSE OF THIS SUBSECTION, "SINGLE  SOURCE
 DRUG" MEANS A BRANDNAME DRUG FOR WHICH THERE IS NO GENERIC EQUIVALENT.
   §  4.  This  act  shall take effect on the first of the calendar month
 next succeeding the sixtieth day after  it  shall  have  become  a  law;
 provided,  however,  that  this  act  shall  apply  only to policies and
 contracts issued, renewed or amended on or after such effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S1893

Sponsored By

Archive: Last Bill Status - In Senate Committee Insurance Committee

2017-S1893 (ACTIVE) - Details

2017-S1893 (ACTIVE) - Summary

2017-S1893 (ACTIVE) - Sponsor Memo

2017-S1893 (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S1893

Share this bill

Sponsored By

Tony Avella

Archive: Last Bill Status - In Senate Committee Insurance Committee

2017-S1893 (ACTIVE) - Details

2017-S1893 (ACTIVE) - Summary

2017-S1893 (ACTIVE) - Sponsor Memo

2017-S1893 (ACTIVE) - Bill Text download pdf

Comments